Gregory Harriman

Greg is the president of Main Line Ventures, an investment and consultancy company offering funding, technical expertise, and executive management experience to entrepreneurs and early stage bioscience and healthcare companies in the Mid-Atlantic region. Greg is an accomplished executive with over 20 years of experience with increasing responsibilities in academic medicine and biopharmaceutical companies. He received his medical degree from the University of California, San Diego and trained at Washington University in St. Louis, MO and the National Institutes of Health in Bethesda, MD. He is board-certified in internal medicine, infectious diseases, and clinical & laboratory immunology. He previously had a successful academic career at the NIH and Baylor College of Medicine, having published over 40 articles and book chapters, receiving NIH and private foundation grant funding, and performing innovative, significant research in immunology, vaccines, and immune-mediated diseases. He is a fellow of the American College of Physicians and is a member of several other professional medical organizations, including the American Academy of Asthma, Allergy & Immunology. He has held leadership positions in several small and large biopharmaceutical companies having global experience in the successful research and development of pharmaceuticals, biologics, medical devices and cell therapies, including a multi-billion dollar product for treatment of immune-related diseases.